Monthly Round-Up of What to Read on Pharma Law and Policy
Bill of Health
JULY 15, 2022
The selections feature topics ranging from a discussion of potential pathways to enable government patent use before nonpatent exclusivities expire, to an examination of medical oncologists who receive more than $100,000 annually from pharmaceutical companies, to an analysis of the launch prices of new drugs from 2008-2021. JAMA Intern Med.
Let's personalize your content